HomeCompareBAX vs PAYX

BAX vs PAYX: Dividend Comparison 2026

BAX yields 2.28% · PAYX yields 4.64%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PAYX wins by $3.53M in total portfolio value
10 years
BAX
BAX
● Live price
2.28%
Share price
$15.80
Annual div
$0.36
5Y div CAGR
-27%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.6K
Annual income
$10.26
Full BAX calculator →
PAYX
PAYX
● Live price
4.64%
Share price
$93.12
Annual div
$4.32
5Y div CAGR
62.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.55M
Annual income
$2,654,302.74
Full PAYX calculator →

Portfolio growth — BAX vs PAYX

📍 PAYX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBAXPAYX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BAX + PAYX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BAX pays
PAYX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BAX
Annual income on $10K today (after 15% tax)
$193.67/yr
After 10yr DRIP, annual income (after tax)
$8.72/yr
PAYX
Annual income on $10K today (after 15% tax)
$394.33/yr
After 10yr DRIP, annual income (after tax)
$2,256,157.33/yr
At 15% tax rate, PAYX beats the other by $2,256,148.61/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BAX + PAYX for your $10,000?

BAX: 50%PAYX: 50%
100% PAYX50/50100% BAX
Portfolio after 10yr
$1.79M
Annual income
$1,327,156.50/yr
Blended yield
74.28%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BAX right now

BAX
Analyst Ratings
15
Buy
20
Hold
1
Sell
Consensus: Hold
Price Target
$19.75
+25.0% upside vs current
Range: $15.00 — $25.00
Altman Z
2.1
Piotroski
5/9
PAYX
Analyst Ratings
4
Buy
20
Hold
6
Sell
Consensus: Hold
Price Target
$117.00
+25.6% upside vs current
Range: $98.00 — $135.00
Altman Z
2.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BAX buys
0
PAYX buys
0
No recent congressional trades found for BAX or PAYX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBAXPAYX
Forward yield2.28%4.64%
Annual dividend / share$0.36$4.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-27%62.1%
Portfolio after 10y$20.6K$3.55M
Annual income after 10y$10.26$2,654,302.74
Total dividends collected$602.00$3.45M
Payment frequencyquarterlyquarterly
SectorHealthcareTechnology
Analyst consensusHoldHold
Analyst price target$19.75$117.00

Year-by-year: BAX vs PAYX ($10,000, DRIP)

YearBAX PortfolioBAX Income/yrPAYX PortfolioPAYX Income/yrGap
1← crossover$10,866$166.33$11,452$752.01$586.00PAYX
2$11,750$123.31$13,558$1,304.68$1.8KPAYX
3$12,664$90.97$16,847$2,340.07$4.2KPAYX
4$13,617$66.89$22,432$4,405.11$8.8KPAYX
5$14,619$49.07$32,888$8,885.61$18.3KPAYX
6$15,679$35.94$54,926$19,735.78$39.2KPAYX
7$16,802$26.30$108,704$49,933.81$91.9KPAYX
8$17,998$19.23$266,029$149,714.93$248.0KPAYX
9$19,272$14.05$839,718$555,067.61$820.4KPAYX
10$20,631$10.26$3,552,801$2,654,302.74$3.53MPAYX

BAX vs PAYX: Complete Analysis 2026

BAXHealthcare

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Full BAX Calculator →

PAYXTechnology

Paychex, Inc. provides integrated human capital management solutions for human resources (HR), payroll, benefits, and insurance services for small to medium-sized businesses in the United States, Europe, and India. It offers payroll processing services; payroll tax administration services; employee payment services; and regulatory compliance services, such as new-hire reporting and garnishment processing. The company also provides HR solutions, including payroll, employer compliance, HR and employee benefits administration, risk management outsourcing, and the on-site availability of a professionally trained HR representative; and retirement services administration, including plan implementation, ongoing compliance with government regulations, employee and employer reporting, participant and employer online access, electronic funds transfer, and other administrative services. In addition, it offers cloud-based HR administration software products for employee benefits management and administration, time and attendance, digital communication solutions, recruiting, and onboarding solutions; plan administration outsourcing and state unemployment insurance services; various business services to small to medium-sized businesses comprising payroll funding and outsourcing services, which include payroll processing, invoicing, and tax preparation; and payment processing services, financial fitness programs, and a small-business loan resource center. Further, the company provides insurance services for property and casualty coverage, such as workers' compensation, business-owner policies, cyber security protection, and commercial auto, as well as health and benefits coverage, including health, dental, vision, and life. It markets and sells its services primarily through its direct sales force. The company was founded in 1971 and is headquartered in Rochester, New York.

Full PAYX Calculator →
📬

Get this BAX vs PAYX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BAX vs SCHDBAX vs JEPIBAX vs OBAX vs KOBAX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.